This page includes Regulatory news filings supplied by issuers listed on the BSX. Please note the BSX is not responsible for the content, accuracy or completeness of announcements filed by issuers and disclaims all liability for any loss arising from reliance on information contained within issuer announcements.
DAIRY FARM COMPLETES INCREASE OF INTEREST IN ROSE PHARMACY, INC TO 100%
Hamilton, Bermuda – 17 December 2018 – In a filing with the Bermuda Stock Exchange (“BSX”), Dairy Farm International Holdings Limited (the “Company”; Ticker: DFIBD.BH) announced the completion of its acquisition of Rose Pharmacy, Inc. The filing stated:
Further to its announcement on 2nd October 2018, Dairy Farm International Holdings Limited is pleased to announce the completion of its acquisition of the remaining 51% interest in Rose Pharmacy, Inc ('RPI') from BRG Realty Corporation, a company owned by the founders of RPI, the Lim Family. As a result of this transaction, Dairy Farm now holds a 100% interest in RPI.
Jonathan Lloyd, Jardine Matheson Limited
For and on behalf of Dairy Farm International Holdings Limited
17th December 2018
www.dairyfarmgroup.com
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END